Ledger.Open graph →
SEC Form D · filed December 30, 2022

Aliada Therapeutics, Inc

Offering
$32.0M
Sold
$32.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Laura J. Tadvalkar · Boston, MADirectorSari Epstein · Boston, MAExecAdam J. Rosenberg · Boston, MAExec · DirectorMarian J. Nakada · Boston, MADirectorJoshua J. Resnick · Boston, MADirectorTristan Wilkerson · Washington, Washington, D.C.Exec · DirectorScott Deffebach · Highland Village, TXExecDavid Friedlaender · Belleair, FLDirectorJim J. Sullivan · Boston, MADirectorBahram A. Motamedian · SAN ANTONIO, TXExec · DirectorRachel A. Donnelly · SAN ANTONIO, TXExecAndra Purkalitis · SAN ANTONIO, TXDirectorMarian J. Nakada · Boston, MADirectorJim J. Sullivan · Boston, MADirectorJoshua J. Resnick · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗